Evidence map›Paper›PMID 42033226›Full record

ArticleNucleic acids research2026

PhoP-regulated VirK acts as an accessory factor to maintain virulence in polymyxin-resistant Klebsiella pneumoniae.

Haibin Li, Longyang Jin, Penghe Wang, Ruobing Wang, Qi Wang, Xiukun Wang, Congran Li, Xuefu You, Hui Wang

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haibin LiDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044,  China.ORCID 0000-0001-7690-9518
Longyang JinDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044,  China.
Penghe WangBeijing Key Laboratory of Technology and Application for Anti-infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050,  China.
Ruobing WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044,  China.
Qi WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044,  China.
Xiukun WangBeijing Key Laboratory of Technology and Application for Anti-infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050,  China.
Congran LiBeijing Key Laboratory of Technology and Application for Anti-infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050,  China.
Xuefu YouBeijing Key Laboratory of Technology and Application for Anti-infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050,  China.
Hui WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044,  China.ORCID 0000-0001-9220-0357

Funding

China Postdoctoral Science Foundation 2024M760145National Natural Science Foundation of China 82330110National Natural Science Foundation of China 82402630Postdoctoral Fellowship Program of CPSF GZC20230148
6 · The paper itself

Abstract

The genetic connection between virulence and antibiotic resistance remains poorly understood. Our previous RNA-Seq analysis of a polymyxin-resistant Klebsiella pneumoniae ATCC BAA2146 mutant identified a highly expressed VirK/YbjX family gene (kpn2146_RS17285), encoding a conserved membrane protein, designated virK (virulence required for Klebsiella pneumoniae). While PhoP-dependent antibiotic resistance is mediated through established pathways such as arn/pmr, we identify VirK as a PhoP-regulated factor specifically contributing to virulence. VirK localizes to the outer membrane and, although not involved in lipopolysaccharide modification, its deletion modestly reduced bacterial virulence in a mouse systemic infection model. Transcriptional and electrophoretic mobility shift assays demonstrated that virK is directly activated by the PhoP protein. A strong positive correlation between virK and phoP expression (r = 0.98) was also observed in multidrug-resistant clinical isolates. Since the PhoP/PhoQ two-component system mediates polymyxin resistance, its direct regulation of VirK uncovers an adaptive mechanism coupling enhanced virulence with antibiotic resistance. These findings reveal a previously unrecognized PhoP/VirK regulatory pathway that contributes to pathogenicity in polymyxin-resistant Klebsiella pneumoniae, offering new insights into bacterial evolution and suggesting that targeting PhoP/PhoQ could provide an effective strategy to combat multidrug-resistant K. pneumoniae infections.

Indexed as

Bacterial ProteinsDrug Resistance, BacterialKlebsiella pneumoniaePolymyxinsVirulence FactorsAnimalsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsGene Expression Regulation, BacterialKlebsiella InfectionsMiceVirulenceAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBacterial ProteinsPhoP protein, BacteriaPolymyxinsVirulence Factors

Identifiers

PMID42033226
PMCPMC13109725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.